| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.67e-07 | 17 | 158 | 5 | GO:0008574 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.19e-06 | 11 | 158 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.34e-06 | 70 | 158 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | CXCR3 chemokine receptor binding | 9.55e-06 | 6 | 158 | 3 | GO:0048248 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.66e-05 | 7 | 158 | 3 | GO:0008443 | |
| GeneOntologyMolecularFunction | kinase binding | HDAC9 TCF3 NEK6 POTEF NTRK1 KIF1B PFKFB1 PFKL CIT GHR POTEE MLXIPL LMNB1 KIF14 ZFYVE26 PKN1 DUSP10 POTEI POTEJ RAPGEF2 BANK1 | 2.67e-05 | 969 | 158 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.30e-05 | 118 | 158 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF18A KIF1A KIF1B PEX1 RNF213 CHD7 DMC1 ABCD3 KIF14 MACF1 KIF18B KIF2C AFG1L | 5.07e-05 | 441 | 158 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.14e-04 | 32 | 158 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.34e-04 | 42 | 158 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | CXCR chemokine receptor binding | 3.63e-04 | 18 | 158 | 3 | GO:0045236 | |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 3.69e-04 | 4 | 158 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A KIF1A KIF1B PEX1 RNF213 CHD7 DNAH1 DMC1 ABCD3 KIF14 MACF1 KIF18B KIF2C AFG1L | 3.83e-04 | 614 | 158 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase binding | HDAC9 TCF3 NEK6 POTEF CIT GHR POTEE MLXIPL LMNB1 KIF14 ZFYVE26 PKN1 DUSP10 POTEI POTEJ RAPGEF2 BANK1 | 5.66e-04 | 873 | 158 | 17 | GO:0019901 |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 5.82e-04 | 21 | 158 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 6.13e-04 | 5 | 158 | 2 | GO:0004331 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 6.13e-04 | 5 | 158 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.94e-04 | 308 | 158 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 9.14e-04 | 6 | 158 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | kinesin binding | 9.40e-04 | 55 | 158 | 4 | GO:0019894 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 6.08e-06 | 35 | 155 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | chromosome segregation | KIF18A NEK6 STAG1 USP9X TEX15 CIT CHMP7 DMC1 KIF14 TNKS KIF18B CEP97 KIF2C | 5.14e-05 | 465 | 155 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | chromosome organization | KIF18A NEK6 STAG1 TEX15 CIT CHMP7 DMC1 PARP4 ATF7IP2 KIF14 TNKS DOT1L KIF18B CEP97 SLX4 KIF2C | 6.14e-05 | 686 | 155 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | KIF18A NEK6 STAG1 TEX15 CIT CHMP7 DMC1 KIF14 KIF18B CEP97 KIF2C | 8.21e-05 | 356 | 155 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 8.24e-05 | 31 | 155 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | organelle fission | KIF18A STAG1 LRRK2 TEX15 CIT CHMP7 DMC1 ANLN NFIB KIF14 KIF18B CEP97 SLX4 KIF2C | 1.07e-04 | 571 | 155 | 14 | GO:0048285 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.33e-04 | 254 | 155 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | nuclear division | KIF18A STAG1 TEX15 CIT CHMP7 DMC1 ANLN NFIB KIF14 KIF18B CEP97 SLX4 KIF2C | 1.35e-04 | 512 | 155 | 13 | GO:0000280 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.43e-04 | 316 | 155 | 10 | GO:0140014 | |
| GeneOntologyBiologicalProcess | cerebellar cortex structural organization | 1.67e-04 | 3 | 155 | 2 | GO:0021698 | |
| GeneOntologyCellularComponent | kinesin complex | 1.88e-06 | 49 | 159 | 6 | GO:0005871 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT72 KIF18A NEK6 KIF1A POTEF KRT85 KIF1B WHAMM KRT87P DNAH1 CHMP7 POTEE PARP4 LMNB1 KIF14 MACF1 POTEI POTEJ KIF18B KIF2C | 1.68e-05 | 899 | 159 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.29e-05 | 161 | 159 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 9.82e-05 | 32 | 159 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 9.82e-05 | 32 | 159 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT72 KIF18A FLNC NEK6 KIF1A POTEF KRT85 KIF1B WHAMM KRT87P DNAH1 CHMP7 POTEE PARP4 LMNB1 KIF14 MACF1 POTEI POTEJ KIF18B KIF2C | 2.45e-04 | 1179 | 159 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | spindle | KIF18A NEK6 STAG1 CEP128 BIRC6 CHMP7 PARP4 FRY KIF14 TNKS KIF18B KIF2C | 2.67e-04 | 471 | 159 | 12 | GO:0005819 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT72 KIF18A FLNC NEK6 KIF1A POTEF KRT85 KIF1B WHAMM KRT87P DNAH1 CHMP7 POTEE PARP4 LMNB1 KIF14 MACF1 POTEI POTEJ KIF18B KIF2C | 2.68e-04 | 1187 | 159 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | midbody | 3.06e-04 | 222 | 159 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.77e-04 | 45 | 159 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | cell cortex | 5.65e-04 | 371 | 159 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | microtubule | KIF18A NEK6 KIF1A KIF1B WHAMM DNAH1 CHMP7 PARP4 KIF14 MACF1 KIF18B KIF2C | 8.00e-04 | 533 | 159 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | centrosome | KIF18A NEK6 CEP85L USP9X ANKRD62 CEP128 BIRC6 FRY AKAP9 CROCC2 ZFYVE26 TNKS G6PD CEP97 KIF2C | 8.10e-04 | 770 | 159 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | pericentriolar material | 1.23e-03 | 28 | 159 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | late endosome | NTRK1 LRRK2 CHMP7 AP5Z1 OSBPL1A ZFYVE26 PLD1 RAPGEF2 CLEC16A | 1.42e-03 | 348 | 159 | 9 | GO:0005770 |
| GeneOntologyCellularComponent | mitotic spindle astral microtubule | 1.56e-03 | 8 | 159 | 2 | GO:0061673 | |
| GeneOntologyCellularComponent | microtubule organizing center | KIF18A NEK6 CEP85L USP9X ANKRD62 CEP128 BIRC6 FRY AKAP9 GLG1 CROCC2 ZFYVE26 TNKS G6PD CEP97 KIF2C | 1.75e-03 | 919 | 159 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | cytoplasmic region | 1.79e-03 | 360 | 159 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | Golgi stack | 2.00e-03 | 171 | 159 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | apical cortex | 2.49e-03 | 10 | 159 | 2 | GO:0045179 | |
| Domain | Ankyrin_rpt | POTEB3 POTEF POTEG LRRK2 POTED ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB BANK1 | 7.13e-13 | 262 | 156 | 19 | IPR002110 |
| Domain | ANK_REPEAT | POTEB3 POTEF POTEG POTED ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB BANK1 | 4.11e-12 | 253 | 156 | 18 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 POTEF POTEG LRRK2 ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB BANK1 | 4.40e-12 | 254 | 156 | 18 | IPR020683 |
| Domain | ANK_REP_REGION | POTEB3 POTEF POTEG POTED ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB BANK1 | 4.40e-12 | 254 | 156 | 18 | PS50297 |
| Domain | - | POTEB3 POTEF POTEG LRRK2 ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ BANK1 | 3.03e-11 | 248 | 156 | 17 | 1.25.40.20 |
| Domain | ANK | POTEB3 POTEF POTEG POTED ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB | 3.67e-11 | 251 | 156 | 17 | SM00248 |
| Domain | Ank_2 | POTEB3 POTEF POTEG POTEB2 POTEC POTEE ASAP2 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ | 3.18e-08 | 215 | 156 | 13 | PF12796 |
| Domain | Ank | POTEF POTEG POTED ANKRD62 POTEC POTEE ASAP2 POTEM OSBPL1A TNKS POTEI POTEJ POTEB | 6.34e-08 | 228 | 156 | 13 | PF00023 |
| Domain | Kinesin_motor_CS | 1.09e-06 | 41 | 156 | 6 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.46e-06 | 43 | 156 | 6 | IPR027640 | |
| Domain | - | 1.67e-06 | 44 | 156 | 6 | 3.40.850.10 | |
| Domain | Kinesin | 1.67e-06 | 44 | 156 | 6 | PF00225 | |
| Domain | KISc | 1.67e-06 | 44 | 156 | 6 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.67e-06 | 44 | 156 | 6 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.67e-06 | 44 | 156 | 6 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.67e-06 | 44 | 156 | 6 | PS50067 | |
| Domain | PH | ARHGEF19 RASA2 KIF1A KIF1B NIBAN3 CIT SPTBN5 ASAP2 ANLN SBF2 OSBPL1A PLD1 | 3.91e-06 | 278 | 156 | 12 | SM00233 |
| Domain | PH_domain | ARHGEF19 RASA2 KIF1A KIF1B NIBAN3 CIT SPTBN5 ASAP2 ANLN SBF2 OSBPL1A PLD1 | 4.21e-06 | 280 | 156 | 12 | IPR001849 |
| Domain | - | ARHGEF19 RASA2 KIF1A KIF1B NIBAN3 CIT SPTBN5 ASAP2 PTPN13 ANLN SBF2 OSBPL1A PLD1 MTMR9 | 5.30e-06 | 391 | 156 | 14 | 2.30.29.30 |
| Domain | Actin_CS | 7.88e-06 | 16 | 156 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 1.02e-05 | 17 | 156 | 4 | PS00432 | |
| Domain | Kinesin_assoc | 1.12e-05 | 6 | 156 | 3 | PF16183 | |
| Domain | Kinesin_assoc | 1.12e-05 | 6 | 156 | 3 | IPR032405 | |
| Domain | Actin/actin-like_CS | 1.31e-05 | 18 | 156 | 4 | IPR020902 | |
| Domain | PH_dom-like | ARHGEF19 RASA2 KIF1A KIF1B NIBAN3 CIT SPTBN5 ASAP2 PTPN13 ANLN SBF2 OSBPL1A PLD1 MTMR9 | 1.40e-05 | 426 | 156 | 14 | IPR011993 |
| Domain | ACTINS_ACT_LIKE | 1.65e-05 | 19 | 156 | 4 | PS01132 | |
| Domain | PH_DOMAIN | ARHGEF19 RASA2 KIF1A KIF1B CIT SPTBN5 ASAP2 ANLN SBF2 OSBPL1A PLD1 | 2.33e-05 | 279 | 156 | 11 | PS50003 |
| Domain | PF4 | 6.93e-05 | 2 | 156 | 2 | IPR027222 | |
| Domain | CABLES1/2 | 6.93e-05 | 2 | 156 | 2 | IPR012388 | |
| Domain | P-loop_NTPase | KIF18A KIF1A KIF1B LRRK2 PEX1 RNF213 CHD7 PFKFB1 PFKFB4 DNAH1 DMC1 NLRP9 TRANK1 ABCD3 KIF14 KIF18B KIF2C AFG1L NLRP5 | 8.66e-05 | 848 | 156 | 19 | IPR027417 |
| Domain | ARM-like | 9.29e-05 | 270 | 156 | 10 | IPR011989 | |
| Domain | - | 1.06e-04 | 222 | 156 | 9 | 1.25.10.10 | |
| Domain | Actin | 1.24e-04 | 31 | 156 | 4 | IPR004000 | |
| Domain | Actin | 1.24e-04 | 31 | 156 | 4 | PF00022 | |
| Domain | ACTIN | 1.24e-04 | 31 | 156 | 4 | SM00268 | |
| Domain | PH | 1.34e-04 | 229 | 156 | 9 | PF00169 | |
| Domain | Chemokine_CXC_CS | 1.54e-04 | 13 | 156 | 3 | IPR018048 | |
| Domain | CXC_Chemokine_domain | 1.94e-04 | 14 | 156 | 3 | IPR033899 | |
| Domain | Chemokine_CXC | 2.96e-04 | 16 | 156 | 3 | IPR001089 | |
| Domain | SMALL_CYTOKINES_CXC | 3.57e-04 | 17 | 156 | 3 | PS00471 | |
| Domain | Kinesin-like_KIF1-typ | 4.11e-04 | 4 | 156 | 2 | IPR022140 | |
| Domain | KIF1B | 4.11e-04 | 4 | 156 | 2 | PF12423 | |
| Domain | 6Phosfructo_kin | 4.11e-04 | 4 | 156 | 2 | IPR013079 | |
| Domain | 6Pfruct_kin | 4.11e-04 | 4 | 156 | 2 | IPR003094 | |
| Domain | 6PF2K | 4.11e-04 | 4 | 156 | 2 | PF01591 | |
| Domain | DAPIN | 7.83e-04 | 22 | 156 | 3 | PS50824 | |
| Domain | PYRIN | 7.83e-04 | 22 | 156 | 3 | SM01289 | |
| Domain | PYRIN | 7.83e-04 | 22 | 156 | 3 | PF02758 | |
| Domain | DAPIN | 7.83e-04 | 22 | 156 | 3 | IPR004020 | |
| Domain | ACTININ_2 | 8.95e-04 | 23 | 156 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.95e-04 | 23 | 156 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.95e-04 | 23 | 156 | 3 | IPR001589 | |
| Domain | Kinesin-like | 1.02e-03 | 6 | 156 | 2 | IPR022164 | |
| Domain | DUF3694 | 1.02e-03 | 6 | 156 | 2 | PF12473 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 1.42e-03 | 7 | 156 | 2 | IPR011330 | |
| Domain | FHA | 1.61e-03 | 28 | 156 | 3 | SM00240 | |
| Domain | Chorein_N | 1.88e-03 | 8 | 156 | 2 | PF12624 | |
| Domain | VPS13_N | 1.88e-03 | 8 | 156 | 2 | IPR026854 | |
| Domain | Leu-rich_rpt | 2.03e-03 | 271 | 156 | 8 | IPR001611 | |
| Domain | FHA_DOMAIN | 2.16e-03 | 31 | 156 | 3 | PS50006 | |
| Domain | FHA | 2.16e-03 | 31 | 156 | 3 | PF00498 | |
| Domain | PG/BPGM_mutase_AS | 2.40e-03 | 9 | 156 | 2 | IPR001345 | |
| Domain | PGAM | 2.99e-03 | 10 | 156 | 2 | SM00855 | |
| Domain | Ank_3 | 2.99e-03 | 10 | 156 | 2 | PF13606 | |
| Domain | PG_MUTASE | 2.99e-03 | 10 | 156 | 2 | PS00175 | |
| Domain | - | 3.33e-03 | 36 | 156 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 3.33e-03 | 36 | 156 | 3 | IPR000253 | |
| Domain | His_Pase_superF_clade-1 | 4.33e-03 | 12 | 156 | 2 | IPR013078 | |
| Domain | His_Phos_1 | 4.33e-03 | 12 | 156 | 2 | PF00300 | |
| Domain | SCY | 5.17e-03 | 42 | 156 | 3 | SM00199 | |
| Domain | - | 5.64e-03 | 321 | 156 | 8 | 3.80.10.10 | |
| Domain | Chemokine_IL8-like_dom | 5.89e-03 | 44 | 156 | 3 | IPR001811 | |
| Domain | IL8 | 5.89e-03 | 44 | 156 | 3 | PF00048 | |
| Domain | Myotubularin-like_Pase_dom | 5.91e-03 | 14 | 156 | 2 | IPR010569 | |
| Domain | uDENN | 5.91e-03 | 14 | 156 | 2 | SM00800 | |
| Domain | PPASE_MYOTUBULARIN | 5.91e-03 | 14 | 156 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 5.91e-03 | 14 | 156 | 2 | IPR030564 | |
| Domain | Myotub-related | 5.91e-03 | 14 | 156 | 2 | PF06602 | |
| Domain | CNH | 5.91e-03 | 14 | 156 | 2 | SM00036 | |
| Domain | L_dom-like | 6.40e-03 | 328 | 156 | 8 | IPR032675 | |
| Domain | uDENN | 6.78e-03 | 15 | 156 | 2 | PF03456 | |
| Domain | CNH | 6.78e-03 | 15 | 156 | 2 | PF00780 | |
| Domain | CNH | 6.78e-03 | 15 | 156 | 2 | PS50219 | |
| Domain | CNH_dom | 6.78e-03 | 15 | 156 | 2 | IPR001180 | |
| Domain | DENN | 7.70e-03 | 16 | 156 | 2 | SM00799 | |
| Domain | DENN | 7.70e-03 | 16 | 156 | 2 | PF02141 | |
| Domain | dDENN | 7.70e-03 | 16 | 156 | 2 | PF03455 | |
| Domain | UDENN | 7.70e-03 | 16 | 156 | 2 | PS50946 | |
| Domain | DDENN | 7.70e-03 | 16 | 156 | 2 | PS50947 | |
| Domain | dDENN | 7.70e-03 | 16 | 156 | 2 | SM00801 | |
| Domain | dDENN_dom | 7.70e-03 | 16 | 156 | 2 | IPR005112 | |
| Domain | uDENN_dom | 7.70e-03 | 16 | 156 | 2 | IPR005113 | |
| Domain | DENN | 7.70e-03 | 16 | 156 | 2 | PS50211 | |
| Domain | DENN_dom | 7.70e-03 | 16 | 156 | 2 | IPR001194 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF19 USP9X WHAMM CIT POTEE PTPN13 CYFIP1 LMNB1 ANLN ABCD3 KIF14 PKN1 PLD1 CEP97 | 1.29e-05 | 450 | 112 | 14 | M27078 |
| Pathway | REACTOME_KINESINS | 8.72e-05 | 57 | 112 | 5 | MM15714 | |
| Pathway | REACTOME_KINESINS | 1.21e-04 | 61 | 112 | 5 | M977 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KIF18A ARHGEF19 USP9X WHAMM CIT POTEE PTPN13 CYFIP1 LMNB1 ANLN ABCD3 KIF14 PKN1 PLD1 CEP97 KIF2C | 1.76e-04 | 720 | 112 | 16 | M41838 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF19 USP9X ANKRD62 WHAMM PTPN13 CYFIP1 LMNB1 ANLN ABCD3 KIF14 PKN1 CEP97 | 1.89e-04 | 439 | 112 | 12 | MM15595 |
| Pubmed | 2.40e-13 | 8 | 160 | 6 | 12475935 | ||
| Pubmed | 7.16e-13 | 9 | 160 | 6 | 16364570 | ||
| Pubmed | 1.16e-11 | 6 | 160 | 5 | 17171436 | ||
| Pubmed | 4.03e-11 | 7 | 160 | 5 | 15276201 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 4.17e-11 | 15 | 160 | 6 | 16824795 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CABLES2 TCF3 NEK6 RASA2 KIF1A KIF1B RNF213 SRPK2 PFKFB1 PFKFB4 PFKL LRRC8D DENND2B DNAH1 ZC3H11A ASAP2 PTPN13 ZNF33B SH3TC1 NFIB SLC22A3 SBF2 ANKAR VPS35L MACF1 PKN1 TTC17 RAPGEF2 CLEC16A | 4.42e-11 | 1489 | 160 | 29 | 28611215 |
| Pubmed | POTEB3 POTEF TMEM51 POTEG POTEB2 POTEC POTEE POTEM POTEI POTEJ POTEB | 2.90e-10 | 163 | 160 | 11 | 24316575 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KIF1A DGKA RNF213 PF4V1 PFKL BIRC6 DARS2 CABLES1 NUP205 POTEE PARP4 FRY LMNB1 ABCD3 UTP20 ZBTB11 BANK1 MTMR9 | 9.81e-09 | 736 | 160 | 18 | 29676528 |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 1.78e-08 | 37 | 160 | 6 | 11416179 | |
| Pubmed | IPO5 HDAC9 STAG1 KIF1A CEP85L USP9X KIF1B WHAMM SRPK2 CIT NFE2L3 FRY UBE2O PTPN13 VPS35L OSBPL1A MACF1 TTC17 TNKS RAPGEF2 ZBTB11 SLX4 BRWD1 | 2.70e-08 | 1285 | 160 | 23 | 35914814 | |
| Pubmed | RASA2 MAP4K3 PEX1 DGKA CHD7 PFKL PGGT1B ZC3H11A PTPN13 ANLN GLG1 SBF2 HPS1 VPS35L ZBTB10 MACF1 PLD1 DOT1L SLX4 KIF2C BRWD1 | 3.05e-08 | 1084 | 160 | 21 | 11544199 | |
| Pubmed | E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. | 9.56e-08 | 3 | 160 | 3 | 17082585 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18384878 | ||
| Pubmed | The helix-loop-helix gene E2A is required for B cell formation. | 9.56e-08 | 3 | 160 | 3 | 8001124 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 30593567 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 9.56e-08 | 3 | 160 | 3 | 17101985 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 1321336 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 8649400 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 11802795 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 27263974 | ||
| Pubmed | Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. | 3.81e-07 | 4 | 160 | 3 | 21771727 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 17342726 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 25466284 | ||
| Pubmed | KIF1A TASP1 WHAMM SRPK2 CHD7 FAM98A PFKL CIT POTEE CELSR1 ZC3H11A PTPN13 CYFIP1 ANLN NFIB GLG1 ABCD3 KIF14 MACF1 UTP20 ZBTB11 TBP KIF2C | 4.09e-07 | 1497 | 160 | 23 | 31527615 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 4.17e-07 | 14 | 160 | 4 | 15333839 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 8999959 | ||
| Pubmed | 1.45e-06 | 76 | 160 | 6 | 27542412 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 9584154 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 10611232 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 17878293 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 12855593 | ||
| Pubmed | Differential cooperation between dHAND and three different E-proteins. | 1.89e-06 | 6 | 160 | 3 | 15351717 | |
| Pubmed | 1.97e-06 | 20 | 160 | 4 | 37684687 | ||
| Pubmed | IPO5 PDGFRA USP9X DGKA RNF213 PFKL CD320 BIRC6 LRRC8D CIT NUP205 PARP4 LMNB1 GLG1 ABCD3 KIF14 PLD1 G6PD KIF2C | 2.00e-06 | 1168 | 160 | 19 | 19946888 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDGFRA CEP85L POTEF KIF1B FAM98A DENND2B MLXIPL VPS13D PTPN13 AKAP9 ANLN KIF14 MACF1 NR3C2 RAPGEF2 KIF2C | 2.56e-06 | 861 | 160 | 16 | 36931259 |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 8759016 | ||
| Pubmed | ID1 and CEBPA coordinate epidermal progenitor cell differentiation. | 3.30e-06 | 7 | 160 | 3 | 36330928 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNC RASA2 MAP4K3 CHD7 FAM98A PFKL BIRC6 NUP205 ZC3H11A CYFIP1 LMNB1 ANLN ABCD3 ZBTB10 PPP1R37 MACF1 UTP20 KIF18B G6PD KIF2C | 4.45e-06 | 1353 | 160 | 20 | 29467282 |
| Pubmed | 5.06e-06 | 25 | 160 | 4 | 32266943 | ||
| Pubmed | GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex. | 5.26e-06 | 8 | 160 | 3 | 22674256 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 11784080 | ||
| Pubmed | E protein dosage influences brain development more than family member identity. | 5.26e-06 | 8 | 160 | 3 | 18214987 | |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 5.26e-06 | 8 | 160 | 3 | 32179550 | |
| Pubmed | 5.68e-06 | 96 | 160 | 6 | 23580065 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 21074528 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | TPMT SRPK2 FAM98A PFKFB1 PFKL CIT PARP4 CELSR1 LMNB1 CROCC2 ABCD3 KIF14 G6PD SPINK5 | 8.07e-06 | 732 | 160 | 14 | 34732716 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 FLNC TCF12 STAG1 SRPK2 PFKL DARS2 NUP205 ZC3H11A SH3TC1 AP5Z1 ZBTB10 UTP20 TBP KIF2C | 1.09e-05 | 857 | 160 | 15 | 25609649 |
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 21828274 | ||
| Pubmed | IPO5 FLNC KIF1A USP9X CHD7 BIRC6 NUP205 ZC3H11A UBE2O KIF14 MACF1 UTP20 ZBTB11 | 1.13e-05 | 653 | 160 | 13 | 22586326 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.18e-05 | 109 | 160 | 6 | 33554859 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP9X KIF1B CHD7 POTEE CYFIP1 KIF14 MACF1 POTEI POTEJ DOT1L SLX4 KIF2C | 1.95e-05 | 588 | 160 | 12 | 38580884 |
| Pubmed | PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons. | 2.04e-05 | 12 | 160 | 3 | 20725507 | |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 2.10e-05 | 2 | 160 | 2 | 28258196 | |
| Pubmed | Platelet factor 4 mediates vascular smooth muscle cell injury responses. | 2.10e-05 | 2 | 160 | 2 | 23568488 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30767316 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20959601 | ||
| Pubmed | Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. | 2.10e-05 | 2 | 160 | 2 | 18248618 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18093538 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23245326 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30917957 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32538218 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27223426 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10958665 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20154672 | ||
| Pubmed | Platelet factor 4 increases bone marrow B cell development and differentiation. | 2.10e-05 | 2 | 160 | 2 | 28914425 | |
| Pubmed | E2A promotes the survival of precursor and mature B lymphocytes. | 2.10e-05 | 2 | 160 | 2 | 16888011 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20525356 | ||
| Pubmed | Evidence for a granule targeting sequence within platelet factor 4. | 2.10e-05 | 2 | 160 | 2 | 15964840 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7539720 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21849473 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20043139 | ||
| Pubmed | CXCL4 is a novel nickel-binding protein and augments nickel allergy. | 2.10e-05 | 2 | 160 | 2 | 28319310 | |
| Pubmed | FcRn augments induction of tissue factor activity by IgG-containing immune complexes. | 2.10e-05 | 2 | 160 | 2 | 32187355 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.10e-05 | 2 | 160 | 2 | 19669888 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7984047 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10319581 | ||
| Pubmed | E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. | 2.10e-05 | 2 | 160 | 2 | 17442955 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16961586 | ||
| Pubmed | Platelet factor 4 induces bone loss by inhibiting the integrin α5-FAK-ERK pathway. | 2.10e-05 | 2 | 160 | 2 | 37565509 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14764524 | ||
| Pubmed | Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias. | 2.10e-05 | 2 | 160 | 2 | 29726929 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25099741 | ||
| Pubmed | Role of kif2c, A Gene Related to ALL Relapse, in Embryonic Hematopoiesis in Zebrafish. | 2.10e-05 | 2 | 160 | 2 | 32354205 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9618760 | ||
| Pubmed | Platelet factor 4 is a biomarker for lymphatic-promoted disorders. | 2.10e-05 | 2 | 160 | 2 | 32525843 | |
| Pubmed | Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules. | 2.10e-05 | 2 | 160 | 2 | 26256688 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20961394 | ||
| Pubmed | Correlation between circulating innate lymphoid cell precursors and thymic function. | 2.10e-05 | 2 | 160 | 2 | 35118353 | |
| Pubmed | CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection. | 2.10e-05 | 2 | 160 | 2 | 30296305 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38839978 | ||
| Pubmed | Identification of a common PEX1 mutation in Zellweger syndrome. | 2.10e-05 | 2 | 160 | 2 | 10447258 | |
| Pubmed | Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. | 2.10e-05 | 2 | 160 | 2 | 26518435 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22792197 | ||
| Pubmed | Functional divergence between 2 chemokines is conferred by single amino acid change. | 2.10e-05 | 2 | 160 | 2 | 20688960 | |
| Pubmed | Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis. | 2.10e-05 | 2 | 160 | 2 | 31722003 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34348486 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25440775 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21111666 | ||
| Pubmed | Decreased Lamin B1 Levels Affect Gene Positioning and Expression in Postmitotic Neurons. | 2.10e-05 | 2 | 160 | 2 | 34058264 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36329090 | ||
| Interaction | POTEC interactions | 3.46e-10 | 13 | 158 | 6 | int:POTEC | |
| Interaction | PLS3 interactions | IPO5 FLNC NTRK1 LRRK2 BAG1 PFKL CIT UBE2O ANLN KIF14 G6PD MNDA | 3.84e-07 | 237 | 158 | 12 | int:PLS3 |
| Interaction | ADAR interactions | HDAC9 STAG1 POTEF NTRK1 SRPK2 CIT POTEE ANLN KIF14 POTEI POTEJ DOT1L SLX4 | 4.26e-07 | 286 | 158 | 13 | int:ADAR |
| Interaction | RAB1C interactions | 6.57e-07 | 22 | 158 | 5 | int:RAB1C | |
| Interaction | TCF23 interactions | 1.71e-06 | 12 | 158 | 4 | int:TCF23 | |
| Interaction | NOL9 interactions | 1.83e-06 | 142 | 158 | 9 | int:NOL9 | |
| Interaction | POTED interactions | 1.88e-06 | 4 | 158 | 3 | int:POTED | |
| Interaction | NEUROD4 interactions | 2.46e-06 | 13 | 158 | 4 | int:NEUROD4 | |
| Interaction | POTEJ interactions | 3.19e-06 | 52 | 158 | 6 | int:POTEJ | |
| Interaction | PPP1CB interactions | IPO5 KIF18A NTRK1 RNF213 CIT DENND2B UBE2O ANLN ZBTB10 PPP1R37 KIF14 DOT1L KIF18B CLEC16A MNDA | 4.47e-06 | 469 | 158 | 15 | int:PPP1CB |
| Interaction | POTEB3 interactions | 7.46e-06 | 35 | 158 | 5 | int:POTEB3 | |
| Interaction | CALM1 interactions | GAD1 TCF4 TCF3 STAG1 KIF1A KIF1B LRRK2 BAG1 CIT ARMC1 VPS13D AKAP9 ANLN ABCD3 KIF14 CEP97 BRWD1 | 8.85e-06 | 626 | 158 | 17 | int:CALM1 |
| Interaction | THOC2 interactions | 9.22e-06 | 219 | 158 | 10 | int:THOC2 | |
| Interaction | ACTR2 interactions | CEP85L POTEF NTRK1 LRRK2 BAG1 CEP128 CIT UBE2O ANLN KIF14 CLEC16A MNDA | 9.56e-06 | 323 | 158 | 12 | int:ACTR2 |
| Interaction | WDR18 interactions | 1.02e-05 | 133 | 158 | 8 | int:WDR18 | |
| Interaction | MYO1B interactions | TCF3 PDGFRA NTRK1 LRRK2 SRPK2 CIT UBE2O ANLN KIF14 DOT1L CLEC16A | 1.07e-05 | 273 | 158 | 11 | int:MYO1B |
| Interaction | FBLL1 interactions | 1.13e-05 | 38 | 158 | 5 | int:FBLL1 | |
| Interaction | NEUROG1 interactions | 1.29e-05 | 19 | 158 | 4 | int:NEUROG1 | |
| Interaction | PTPN3 interactions | 1.39e-05 | 100 | 158 | 7 | int:PTPN3 | |
| Interaction | KIF2C interactions | 1.45e-05 | 183 | 158 | 9 | int:KIF2C | |
| Interaction | SPDEF interactions | 1.47e-05 | 40 | 158 | 5 | int:SPDEF | |
| Interaction | ACTG1 interactions | POTEF LRRK2 WHAMM SRPK2 POTEE UBE2O CYFIP1 TTC23 ANLN NR3C2 PLD1 POTEI POTEJ G6PD SLX4 | 1.52e-05 | 520 | 158 | 15 | int:ACTG1 |
| Interaction | FAM228B interactions | 1.62e-05 | 7 | 158 | 3 | int:FAM228B | |
| Interaction | DDX47 interactions | 1.65e-05 | 186 | 158 | 9 | int:DDX47 | |
| Interaction | ANKS3 interactions | 1.66e-05 | 41 | 158 | 5 | int:ANKS3 | |
| Interaction | YWHAH interactions | CEP85L POTEF NTRK1 KIF1B LRRK2 BAG1 FAM98A PFKFB4 CEP128 DENND2B MLXIPL VPS13D PTPN13 CYFIP1 AKAP9 ANLN KIF14 MACF1 NR3C2 RAPGEF2 CLEC16A G6PD KIF2C | 1.67e-05 | 1102 | 158 | 23 | int:YWHAH |
| Interaction | NOP16 interactions | 2.04e-05 | 191 | 158 | 9 | int:NOP16 | |
| Interaction | TSNAX interactions | 2.30e-05 | 194 | 158 | 9 | int:TSNAX | |
| Interaction | CNTNAP4 interactions | 2.38e-05 | 22 | 158 | 4 | int:CNTNAP4 | |
| Interaction | GTF3C4 interactions | 2.40e-05 | 195 | 158 | 9 | int:GTF3C4 | |
| Interaction | UBA6 interactions | 2.45e-05 | 150 | 158 | 8 | int:UBA6 | |
| Interaction | RNF123 interactions | FLNC KIF1A DGKA RNF213 PF4V1 PFKL BIRC6 DARS2 CABLES1 NUP205 POTEE PARP4 FRY LMNB1 ABCD3 UTP20 ZBTB11 BANK1 MTMR9 | 2.55e-05 | 824 | 158 | 19 | int:RNF123 |
| Interaction | IRF2BP2 interactions | 2.58e-05 | 110 | 158 | 7 | int:IRF2BP2 | |
| Interaction | NES interactions | 2.70e-05 | 152 | 158 | 8 | int:NES | |
| Interaction | PWP1 interactions | 2.70e-05 | 198 | 158 | 9 | int:PWP1 | |
| Interaction | PNN interactions | NTRK1 SRPK2 SARNP BIRC6 CIT ZC3H11A UBE2O ANLN KIF14 DOT1L CLEC16A | 2.73e-05 | 302 | 158 | 11 | int:PNN |
| Interaction | NONO interactions | TCF3 NTRK1 BAG1 RNF213 CIT POTEE ZC3H11A AKAP9 TTC23 ANLN ZBTB10 KIF14 DOT1L G6PD SLX4 | 2.86e-05 | 549 | 158 | 15 | int:NONO |
| Interaction | DYRK1A interactions | FLNC KIF1A NTRK1 SRPK2 CIT ANLN OSBPL1A ABCD3 KIF14 RAPGEF2 ZBTB11 CLEC16A G6PD SLX4 TBP | 3.05e-05 | 552 | 158 | 15 | int:DYRK1A |
| Interaction | PES1 interactions | 3.78e-05 | 258 | 158 | 10 | int:PES1 | |
| Interaction | MESP2 interactions | 3.84e-05 | 9 | 158 | 3 | int:MESP2 | |
| Interaction | ATOH1 interactions | 3.93e-05 | 80 | 158 | 6 | int:ATOH1 | |
| Interaction | ACTG2 interactions | 4.01e-05 | 49 | 158 | 5 | int:ACTG2 | |
| Interaction | CEP170 interactions | USP9X NTRK1 SRPK2 CEP128 CIT AKAP9 ANLN KIF14 TNKS CLEC16A KIF2C | 4.36e-05 | 318 | 158 | 11 | int:CEP170 |
| Interaction | MFN1 interactions | 4.43e-05 | 50 | 158 | 5 | int:MFN1 | |
| Interaction | YWHAB interactions | IPO5 CEP85L POTEF NTRK1 KIF1B LRRK2 BAG1 SRPK2 PFKFB4 DENND2B VPS13D PTPN13 CYFIP1 AKAP9 LMNB1 ANLN KIF14 MACF1 DOT1L RAPGEF2 G6PD | 4.52e-05 | 1014 | 158 | 21 | int:YWHAB |
| Interaction | UBA1 interactions | IPO5 NTRK1 BAG1 CIT INPP4B FRA10AC1 ANLN SBF2 ABCD3 KIF14 G6PD SLX4 | 4.73e-05 | 380 | 158 | 12 | int:UBA1 |
| Interaction | RHOT2 interactions | IPO5 NTRK1 PEX1 SPTBN5 CHMP7 VPS13D ANLN ABCD3 KIF14 TTC17 CLEC16A | 4.75e-05 | 321 | 158 | 11 | int:RHOT2 |
| Interaction | CXCL11 interactions | 4.75e-05 | 26 | 158 | 4 | int:CXCL11 | |
| Interaction | MKI67 interactions | IPO5 HDAC9 KIF18A SRPK2 CHD7 CIT ZC3H11A TTC23 ANLN ABCD3 KIF14 UTP20 DOT1L KIF18B MNDA SLX4 | 5.19e-05 | 648 | 158 | 16 | int:MKI67 |
| Interaction | NUP93 interactions | 5.37e-05 | 269 | 158 | 10 | int:NUP93 | |
| Interaction | PPIL2 interactions | 6.32e-05 | 87 | 158 | 6 | int:PPIL2 | |
| Interaction | RTRAF interactions | 6.59e-05 | 222 | 158 | 9 | int:RTRAF | |
| Interaction | DDX18 interactions | NTRK1 SRPK2 CIT UBE2O LMNB1 ANLN KIF14 UTP20 DOT1L MNDA SLX4 | 6.78e-05 | 334 | 158 | 11 | int:DDX18 |
| Interaction | HSP90AA2P interactions | 7.05e-05 | 55 | 158 | 5 | int:HSP90AA2P | |
| Interaction | SNRNP200 interactions | STAG1 USP9X NTRK1 SRPK2 PFKL CIT UBE2O LMNB1 ANLN ZBTB10 KIF14 DOT1L SLX4 | 7.09e-05 | 460 | 158 | 13 | int:SNRNP200 |
| Interaction | TEX10 interactions | 7.33e-05 | 175 | 158 | 8 | int:TEX10 | |
| Interaction | RBM15 interactions | 7.33e-05 | 175 | 158 | 8 | int:RBM15 | |
| Interaction | NUP133 interactions | 7.33e-05 | 175 | 158 | 8 | int:NUP133 | |
| Interaction | RPL39P5 interactions | 7.41e-05 | 29 | 158 | 4 | int:RPL39P5 | |
| Interaction | NLRP9 interactions | 7.45e-05 | 11 | 158 | 3 | int:NLRP9 | |
| Interaction | NOM1 interactions | 7.51e-05 | 130 | 158 | 7 | int:NOM1 | |
| Interaction | CRNKL1 interactions | 7.94e-05 | 177 | 158 | 8 | int:CRNKL1 | |
| Interaction | RFC3 interactions | 7.94e-05 | 177 | 158 | 8 | int:RFC3 | |
| Interaction | TERF2 interactions | USP9X CHD7 PFKL DARS2 POTEE CYFIP1 ZBTB10 MACF1 TNKS SLX4 TBP | 7.95e-05 | 340 | 158 | 11 | int:TERF2 |
| Interaction | KIFBP interactions | 8.93e-05 | 180 | 158 | 8 | int:KIFBP | |
| Interaction | POTEKP interactions | 9.11e-05 | 58 | 158 | 5 | int:POTEKP | |
| Interaction | LAS1L interactions | 9.65e-05 | 182 | 158 | 8 | int:LAS1L | |
| Interaction | UBTF interactions | 9.86e-05 | 234 | 158 | 9 | int:UBTF | |
| Interaction | POTEG interactions | 9.88e-05 | 12 | 158 | 3 | int:POTEG | |
| Interaction | ARPC3 interactions | 1.00e-04 | 183 | 158 | 8 | int:ARPC3 | |
| Interaction | USP10 interactions | 1.00e-04 | 290 | 158 | 10 | int:USP10 | |
| Interaction | SRSF2 interactions | 1.00e-04 | 290 | 158 | 10 | int:SRSF2 | |
| Interaction | RIC8A interactions | 1.09e-04 | 96 | 158 | 6 | int:RIC8A | |
| Interaction | YWHAG interactions | CEP85L MAP4K3 POTEF NTRK1 KRT85 KIF1B LRRK2 BAG1 FAM98A PFKFB4 DENND2B MLXIPL VPS13D PTPN13 CYFIP1 AKAP9 ANLN KIF14 MACF1 RAPGEF2 G6PD CEP97 KIF2C | 1.13e-04 | 1248 | 158 | 23 | int:YWHAG |
| Interaction | EIF4A1 interactions | 1.16e-04 | 355 | 158 | 11 | int:EIF4A1 | |
| Interaction | KRT18 interactions | IPO5 KRT72 CEP128 BIRC6 NUP205 UBE2O ANLN ABCD3 KIF14 DOT1L G6PD CEP97 | 1.20e-04 | 419 | 158 | 12 | int:KRT18 |
| Interaction | IMPDH2 interactions | IPO5 NTRK1 BAG1 ATG2B CIT UBE2O CYFIP1 AKAP9 ANLN VPS35L KIF14 CLEC16A | 1.22e-04 | 420 | 158 | 12 | int:IMPDH2 |
| Interaction | RPL13AP3 interactions | 1.25e-04 | 33 | 158 | 4 | int:RPL13AP3 | |
| Interaction | ALDH18A1 interactions | 1.25e-04 | 189 | 158 | 8 | int:ALDH18A1 | |
| Interaction | KIF2A interactions | 1.27e-04 | 242 | 158 | 9 | int:KIF2A | |
| Interaction | TAL2 interactions | 1.28e-04 | 13 | 158 | 3 | int:TAL2 | |
| Interaction | TCF15 interactions | 1.28e-04 | 13 | 158 | 3 | int:TCF15 | |
| Interaction | HSD17B4 interactions | 1.30e-04 | 190 | 158 | 8 | int:HSD17B4 | |
| Interaction | NKRF interactions | 1.35e-04 | 244 | 158 | 9 | int:NKRF | |
| Interaction | NAT10 interactions | 1.40e-04 | 302 | 158 | 10 | int:NAT10 | |
| Interaction | HAND2 interactions | 1.40e-04 | 34 | 158 | 4 | int:HAND2 | |
| Interaction | ACTR3 interactions | 1.51e-04 | 305 | 158 | 10 | int:ACTR3 | |
| Interaction | FXR2 interactions | KIF1A NTRK1 SRPK2 FAM98A CIT CYFIP1 AKAP9 ANLN ZBTB10 KIF14 DOT1L CLEC16A | 1.52e-04 | 430 | 158 | 12 | int:FXR2 |
| Interaction | PSMD13 interactions | 1.55e-04 | 306 | 158 | 10 | int:PSMD13 | |
| Interaction | GNB1 interactions | PDGFRA NTRK1 RNF213 CEP128 UBE2O CYFIP1 ANLN KIF14 DOT1L CLEC16A | 1.60e-04 | 307 | 158 | 10 | int:GNB1 |
| Interaction | PRSS56 interactions | 1.62e-04 | 14 | 158 | 3 | int:PRSS56 | |
| Interaction | ASCL3 interactions | 1.62e-04 | 14 | 158 | 3 | int:ASCL3 | |
| Interaction | NOP58 interactions | 1.68e-04 | 309 | 158 | 10 | int:NOP58 | |
| Interaction | TCF12 interactions | 1.69e-04 | 148 | 158 | 7 | int:TCF12 | |
| Interaction | WDR75 interactions | 1.70e-04 | 104 | 158 | 6 | int:WDR75 | |
| Interaction | AKAP1 interactions | IPO5 USP9X NTRK1 ATG2B PEX1 BIRC6 CABLES1 NUP205 CHMP7 POTEE VPS13D ABCD3 UTP20 | 1.72e-04 | 503 | 158 | 13 | int:AKAP1 |
| Interaction | SAP30BP interactions | 1.79e-04 | 105 | 158 | 6 | int:SAP30BP | |
| Interaction | POTEM interactions | 1.82e-04 | 3 | 158 | 2 | int:POTEM | |
| Interaction | RRP1B interactions | 1.91e-04 | 314 | 158 | 10 | int:RRP1B | |
| Interaction | CSE1L interactions | 1.91e-04 | 314 | 158 | 10 | int:CSE1L | |
| Cytoband | 4q12-q21 | 1.24e-05 | 2 | 162 | 2 | 4q12-q21 | |
| Cytoband | 2q21.1 | 5.46e-05 | 58 | 162 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | POTEF POTEG POTED POTEB2 POTEC POTEE POTEM POTEI POTEJ POTEB | 1.29e-20 | 13 | 110 | 10 | 685 |
| GeneFamily | Ankyrin repeat domain containing | POTEF POTEG POTED ANKRD62 POTEB2 POTEC POTEE ASAP2 TRANK1 POTEM ANKAR OSBPL1A TNKS POTEI POTEJ POTEB BANK1 | 1.03e-13 | 242 | 110 | 17 | 403 |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.40e-07 | 46 | 110 | 6 | 622 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 2.18e-04 | 4 | 110 | 2 | 1077 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.66e-04 | 206 | 110 | 7 | 682 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 4.57e-04 | 25 | 110 | 3 | 994 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.66e-03 | 15 | 110 | 2 | 903 | |
| GeneFamily | Basic helix-loop-helix proteins | 4.57e-03 | 110 | 110 | 4 | 420 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.70e-03 | 17 | 110 | 2 | 684 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.35e-03 | 115 | 110 | 4 | 769 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | IPO5 HDAC9 POTEB3 GAD1 MAP4K3 POTEF POTEG POTEB2 POTEC POTEE POTEM ANLN POTEI POTEJ POTEB | 3.18e-06 | 584 | 160 | 15 | MM1080 |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 3.77e-06 | 198 | 160 | 9 | M5591 | |
| Coexpression | GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP | 4.09e-06 | 200 | 160 | 9 | M4335 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TCF12 STAG1 USP9X SRPK2 DENND2B USP6 ASAP2 PTPN13 AKAP9 LMNB1 NFIB KIF14 MACF1 UTP20 TNKS RAPGEF2 ZBTB11 CLEC16A | 5.29e-06 | 856 | 160 | 18 | M4500 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 1.49e-05 | 179 | 160 | 8 | M3268 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.55e-05 | 180 | 160 | 8 | M8239 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | IPO5 GAD1 KIF18A TCF3 TCF12 KIF1B RNF213 SARNP ARMC1 NUP205 GHR NFE2L3 ZC3H11A LMNB1 ANLN OSBPL1A KIF14 MTRR PLAU KIF18B CXCL11 MNDA KIF2C | 1.57e-05 | 1407 | 160 | 23 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TCF12 STAG1 USP9X SRPK2 USP6 ASAP2 AKAP9 NFIB KIF14 RAPGEF2 CLEC16A G6PD | 3.11e-05 | 466 | 160 | 12 | M13522 |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 3.31e-05 | 200 | 160 | 8 | M7807 | |
| Coexpression | YU_MYC_TARGETS_DN | 6.09e-05 | 68 | 160 | 5 | MM632 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 6.09e-05 | 68 | 160 | 5 | M41108 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | HDAC9 TCF4 TCF12 USP9X KIF1B PEX1 CD320 FRA10AC1 CELSR1 ZNF33B VPS35L UTP20 DUSP10 RAPGEF2 FAM118A G6PD CEP97 | 6.72e-05 | 942 | 160 | 17 | M8144 |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | HDAC9 TCF3 LRRK2 NIBAN3 FRY SH3TC1 ANLN SBF2 DUSP10 KIF18B IL4I1 BANK1 KIF2C | 3.36e-06 | 372 | 154 | 13 | GSM538204_500 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-08 | 180 | 162 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-08 | 187 | 162 | 9 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.47e-08 | 196 | 162 | 9 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.67e-08 | 197 | 162 | 9 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-07 | 174 | 162 | 8 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-07 | 175 | 162 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-07 | 180 | 162 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-07 | 187 | 162 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.75e-07 | 189 | 162 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.95e-07 | 190 | 162 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.15e-07 | 191 | 162 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.35e-07 | 192 | 162 | 8 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 5.57e-07 | 193 | 162 | 8 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.57e-07 | 193 | 162 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.02e-07 | 195 | 162 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.02e-07 | 195 | 162 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-07 | 195 | 162 | 8 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.26e-07 | 196 | 162 | 8 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.26e-07 | 196 | 162 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.26e-07 | 196 | 162 | 8 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 6.26e-07 | 196 | 162 | 8 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.50e-07 | 197 | 162 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.76e-07 | 198 | 162 | 8 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 7.02e-07 | 199 | 162 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.02e-07 | 199 | 162 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 7.02e-07 | 199 | 162 | 8 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 200 | 162 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 7.29e-07 | 200 | 162 | 8 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 7.29e-07 | 200 | 162 | 8 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 7.29e-07 | 200 | 162 | 8 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-06 | 149 | 162 | 7 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 2.11e-06 | 161 | 162 | 7 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-06 | 163 | 162 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 163 | 162 | 7 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 169 | 162 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 169 | 162 | 7 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-06 | 170 | 162 | 7 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 172 | 162 | 7 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.38e-06 | 63 | 162 | 5 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 174 | 162 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 3.81e-06 | 176 | 162 | 7 | 50fe3fd862dd6a6550ebb8c27f337cde468efedc | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 3.95e-06 | 177 | 162 | 7 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.25e-06 | 179 | 162 | 7 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-06 | 179 | 162 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-06 | 181 | 162 | 7 | 75035a3211e524bb659b82e6979f7d3a3121ae70 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 182 | 162 | 7 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 4.92e-06 | 183 | 162 | 7 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.28e-06 | 185 | 162 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-06 | 185 | 162 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.28e-06 | 185 | 162 | 7 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 186 | 162 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-06 | 186 | 162 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-06 | 187 | 162 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-06 | 187 | 162 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-06 | 187 | 162 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.87e-06 | 188 | 162 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.87e-06 | 188 | 162 | 7 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-06 | 189 | 162 | 7 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-06 | 189 | 162 | 7 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.08e-06 | 189 | 162 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.08e-06 | 189 | 162 | 7 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-06 | 189 | 162 | 7 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.29e-06 | 190 | 162 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.29e-06 | 190 | 162 | 7 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.29e-06 | 190 | 162 | 7 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | Control-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.51e-06 | 191 | 162 | 7 | 33fce8e086601e636e8c6ef2ab58fcfdd52af369 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.51e-06 | 191 | 162 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.74e-06 | 192 | 162 | 7 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.74e-06 | 192 | 162 | 7 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 6.74e-06 | 192 | 162 | 7 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.97e-06 | 193 | 162 | 7 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.21e-06 | 194 | 162 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.21e-06 | 194 | 162 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-06 | 194 | 162 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.21e-06 | 194 | 162 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 7.21e-06 | 194 | 162 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.21e-06 | 194 | 162 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.21e-06 | 194 | 162 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.21e-06 | 194 | 162 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.21e-06 | 194 | 162 | 7 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.21e-06 | 194 | 162 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.46e-06 | 195 | 162 | 7 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.46e-06 | 195 | 162 | 7 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.46e-06 | 195 | 162 | 7 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 195 | 162 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.46e-06 | 195 | 162 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-06 | 195 | 162 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.71e-06 | 196 | 162 | 7 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 196 | 162 | 7 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.71e-06 | 196 | 162 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.71e-06 | 196 | 162 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.71e-06 | 196 | 162 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.71e-06 | 196 | 162 | 7 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 196 | 162 | 7 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.71e-06 | 196 | 162 | 7 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.71e-06 | 196 | 162 | 7 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 196 | 162 | 7 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; PC3; HT_HG-U133A | IPO5 TCF4 PEX1 SRPK2 PGGT1B VPS13D CELSR1 AP5Z1 VPS35L ZBTB10 TMCO3 | 1.17e-07 | 199 | 154 | 11 | 6342_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.96e-06 | 174 | 154 | 9 | 7530_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 7.49e-06 | 195 | 154 | 9 | 5825_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 7.81e-06 | 196 | 154 | 9 | 1346_UP | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 7383_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 8.47e-06 | 198 | 154 | 9 | 5858_DN | |
| Drug | glipentide | 1.04e-05 | 7 | 154 | 3 | CID000065779 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 1.29e-07 | 3 | 150 | 3 | DOID:0060488 (implicated_via_orthology) | |
| Disease | myeloid white cell count | HDAC9 TCF4 RASA2 NTRK1 KIF1B UBL4B CHD7 CIT DENND2B MLXIPL UBE2O GLG1 SBF2 TMCO3 DOT1L | 9.10e-05 | 937 | 150 | 15 | EFO_0007988 |
| Disease | total blood protein measurement | CABLES2 STAG1 RASA2 MAP4K3 PF4V1 DNAH1 SLC22A3 SBF2 MACF1 CLEC16A | 1.06e-04 | 449 | 150 | 10 | EFO_0004536 |
| Disease | neuroimaging measurement | HDAC9 TCF4 STAG1 KIF1B CHD7 FAM98A CHMP7 MLXIPL CELSR1 SEC14L6 NFIB MACF1 PLD1 RAPGEF2 KIF18B BANK1 | 1.15e-04 | 1069 | 150 | 16 | EFO_0004346 |
| Disease | platelet component distribution width | HDAC9 LRRK2 RIPOR3 INPP4B CABLES1 MLXIPL UBE2O CYFIP1 TRANK1 ZBTB10 MACF1 NR3C2 BRWD1 | 1.34e-04 | 755 | 150 | 13 | EFO_0007984 |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 1.53e-04 | 4 | 150 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | synucleinopathy (biomarker_via_orthology) | 1.53e-04 | 4 | 150 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 1.53e-04 | 4 | 150 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | growth-regulated alpha protein measurement | 1.79e-04 | 55 | 150 | 4 | EFO_0008146 | |
| Disease | mean platelet volume | HDAC9 TCF12 KIF1B LRRK2 CHD7 PFKFB4 LRRC8D DENND2B CABLES1 MLXIPL FRY TRANK1 ZBTB10 NR3C2 BANK1 | 2.29e-04 | 1020 | 150 | 15 | EFO_0004584 |
| Disease | Headache | 3.22e-04 | 64 | 150 | 4 | HP_0002315 | |
| Disease | Manic Disorder | 4.78e-04 | 71 | 150 | 4 | C0024713 | |
| Disease | hereditary spastic paraplegia (is_implicated_in) | 5.30e-04 | 7 | 150 | 2 | DOID:2476 (is_implicated_in) | |
| Disease | Manic | 6.83e-04 | 78 | 150 | 4 | C0338831 | |
| Disease | schizophrenia (is_implicated_in) | 6.83e-04 | 78 | 150 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Depression, Bipolar | 7.17e-04 | 79 | 150 | 4 | C0005587 | |
| Disease | pulse pressure measurement | HDAC9 TCF4 NEK6 PDGFRA LRRC69 RNF213 SARNP ASAP2 CYFIP1 TRANK1 ZNF33B SLC22A3 SBF2 DOT1L FAM118A CLEC16A CEP97 | 7.42e-04 | 1392 | 150 | 17 | EFO_0005763 |
| Disease | Bipolar Disorder | 7.78e-04 | 477 | 150 | 9 | C0005586 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 8.10e-04 | 295 | 150 | 7 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0800314 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.06e-03 | 225 | 150 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 1.11e-03 | 227 | 150 | 6 | EFO_0020946 | |
| Disease | Moyamoya disease | 1.11e-03 | 40 | 150 | 3 | MONDO_0016820 | |
| Disease | platelet measurement | 1.18e-03 | 315 | 150 | 7 | EFO_0005036 | |
| Disease | albuminuria | 1.37e-03 | 94 | 150 | 4 | EFO_0004285 | |
| Disease | cortical surface area measurement | HDAC9 TCF4 STAG1 KIF1B LRRC69 SRPK2 CHD7 CHMP7 CELSR1 NFIB VPS35L MACF1 TNKS NR3C2 FAM118A BANK1 | 1.40e-03 | 1345 | 150 | 16 | EFO_0010736 |
| Disease | dyslexia | 1.46e-03 | 162 | 150 | 5 | EFO_0005424 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.64e-03 | 12 | 150 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | fatty acid measurement | 1.81e-03 | 436 | 150 | 8 | EFO_0005110 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.92e-03 | 103 | 150 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Hypermetropia | 1.92e-03 | 103 | 150 | 4 | HP_0000540 | |
| Disease | Zellweger Spectrum | 1.93e-03 | 13 | 150 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 1.93e-03 | 13 | 150 | 2 | C0751594 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.00e-03 | 49 | 150 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.12e-03 | 50 | 150 | 3 | EFO_0022247 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 2.24e-03 | 14 | 150 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 2.33e-03 | 355 | 150 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | granulocyte percentage of myeloid white cells | 2.55e-03 | 268 | 150 | 6 | EFO_0007997 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.78e-03 | 55 | 150 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Zellweger Syndrome | 2.94e-03 | 16 | 150 | 2 | C0043459 | |
| Disease | pro-hydroxy-pro measurement | 2.94e-03 | 16 | 150 | 2 | EFO_0021132 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.94e-03 | 16 | 150 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.95e-03 | 276 | 150 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.14e-03 | 118 | 150 | 4 | EFO_0010119 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 3.32e-03 | 17 | 150 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | rhinitis | 3.32e-03 | 17 | 150 | 2 | EFO_0008521 | |
| Disease | hypothyroidism | 3.40e-03 | 284 | 150 | 6 | EFO_0004705 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.44e-03 | 121 | 150 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | C-reactive protein measurement | GAD1 TCF4 NEK6 RIPOR3 CHD7 CIT DMC1 MLXIPL TRANK1 NFIB PPP1R37 MACF1 TNKS BANK1 | 3.46e-03 | 1206 | 150 | 14 | EFO_0004458 |
| Disease | cholesterol to total lipids in IDL percentage | 3.56e-03 | 60 | 150 | 3 | EFO_0022233 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.64e-03 | 200 | 150 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | neutrophil percentage of leukocytes | 4.11e-03 | 610 | 150 | 9 | EFO_0007990 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 4.13e-03 | 206 | 150 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | response to methotrexate, neurotoxicity | 4.15e-03 | 19 | 150 | 2 | EFO_0011057, GO_0031427 | |
| Disease | alcohol consumption measurement | TCF4 KCNH7 RASA2 BIRC6 CIT INPP4B SPTBN5 DMC1 MLXIPL ST6GAL2 AKAP9 NR3C2 CLEC16A BANK1 | 4.48e-03 | 1242 | 150 | 14 | EFO_0007878 |
| Disease | Liver carcinoma | 4.53e-03 | 507 | 150 | 8 | C2239176 | |
| Disease | Hemorrhage | 4.59e-03 | 20 | 150 | 2 | C0019080 | |
| Disease | neutrophil count | NEK6 RASA2 NTRK1 KIF1B SRPK2 RIPOR3 CHD7 CIT DENND2B CABLES1 MLXIPL GLG1 SBF2 OSBPL1A TMCO3 | 4.65e-03 | 1382 | 150 | 15 | EFO_0004833 |
| Disease | sclerosing cholangitis | 4.66e-03 | 66 | 150 | 3 | EFO_0004268 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.86e-03 | 67 | 150 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 5.06e-03 | 21 | 150 | 2 | C1292769 | |
| Disease | cytotoxicity measurement, response to metformin | 5.06e-03 | 21 | 150 | 2 | EFO_0006952, GO_1901558 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 5.07e-03 | 68 | 150 | 3 | EFO_0007826, EFO_0007860 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEKLRQLRDCIIGKR | 716 | Q8NDB2 | |
| GNCKTRNLVLKLLLN | 456 | Q6PI77 | |
| ALQIRKQCALAALKD | 101 | P16118 | |
| EALKQLSLAGREKLC | 1661 | Q99996 | |
| KCKLGIQRLNISRND | 616 | Q96N23 | |
| RGQLEKLKSQCDRLT | 751 | Q6ZU80 | |
| KLNSALCNRRKGELE | 771 | Q9NR09 | |
| ILKVQGRELRLNKAC | 326 | Q8WV93 | |
| SRRNLCEEALLKIKG | 156 | Q9NVT9 | |
| NDRDKKNRTALLLAC | 66 | A6NC57 | |
| LQAEALCKLDRRVKA | 266 | Q99933 | |
| RALRKGDSDLQKACL | 311 | O43299 | |
| LKGRLREKLADCEQS | 2946 | Q9NYQ6 | |
| ALRGQSLQLLKARCE | 591 | Q8TEK3 | |
| RRALCNVKGLSEAKV | 56 | Q14565 | |
| IQDRELRKCRAKGLF | 1086 | P78524 | |
| LRKCRAKGLFEQRVE | 1091 | P78524 | |
| EAHRLKNRNCKLLEG | 1106 | Q9P2D1 | |
| DLIQSLLCGQKERLK | 336 | O14578 | |
| GLAQLNCSELKLKRL | 1841 | Q96BY7 | |
| GLAVKDACQTLLKRL | 1096 | Q06278 | |
| LECRQALVRNKHGKA | 46 | A0A1B0GUU1 | |
| QKGKIRRIDCLRQAD | 111 | O00712 | |
| VLQSLRGKICEAKNL | 36 | Q15283 | |
| LRCGKALNERKAEVR | 356 | P11413 | |
| IRGCLLQRIDQELKK | 576 | Q86XR2 | |
| VVGRNKLLQCLHAKR | 1266 | Q92621 | |
| LDRRCQLNVLDNKKR | 156 | H3BUK9 | |
| CDLKKLRILDIAGNI | 196 | Q6ZNQ3 | |
| NDCLLLSRRKELGKF | 626 | Q8IW93 | |
| ANAFRILLKECRNKP | 1286 | Q7Z5J8 | |
| CLAKNLLGAENRELK | 501 | P16234 | |
| LLLDKRLRSECKNQG | 721 | Q7L576 | |
| RCQLNVLDNKKRTAL | 196 | A5A3E0 | |
| LDCCIKIVNLQGRLK | 791 | Q8IVH8 | |
| LVCKDENGQRKQPLR | 506 | Q15058 | |
| LLVLNKCGRRNKFGI | 436 | P04629 | |
| GRNDCIIDKIRRKNC | 641 | P08235 | |
| GRRCKEDEKLINATL | 211 | Q96QG7 | |
| LRALKGKAARQCLTD | 576 | Q86WG5 | |
| ARCKLAELEGALQKA | 381 | P78386 | |
| RKLVRNGKLACTREN | 371 | Q9NQ38 | |
| NDSEGDNCKLRRRKL | 881 | Q9NS40 | |
| KLTRLLKDSLGGNCQ | 311 | Q8NI77 | |
| CERVRDLLNPKNKGN | 151 | O60333 | |
| QLKQERQKELACLRG | 426 | Q9NQW6 | |
| TDNAECLKLLLRGKA | 631 | O43150 | |
| DKKLRNCSRLACLAG | 121 | Q9NPF0 | |
| REGCRIENVLKNIKC | 881 | O15327 | |
| VRERNLNPKAACLKR | 621 | P15884 | |
| AEKRRLQELCSKQGA | 396 | Q9UBK8 | |
| TARERAKLQIELGKC | 96 | P20700 | |
| CADKISRRRLQQGKI | 196 | Q9Y6W6 | |
| ELEKALKACEGRQSR | 96 | A0A1B0GVG4 | |
| RKLGLKICGFLQRTN | 41 | Q99259 | |
| KRNALVKLRLCQECS | 201 | Q70Z53 | |
| IATLKNGRKICLDLQ | 76 | P10720 | |
| KTDIQRGLVLRNEKC | 616 | P17858 | |
| NEEGLKIRKQCALAA | 96 | Q16877 | |
| AAQNCRKRKLDIILN | 591 | Q9Y4A8 | |
| KCVGKRLTDLQRDLS | 51 | Q14315 | |
| ERNLNPKAACLKRRE | 636 | Q99081 | |
| KLKNAGRRLAKCSEI | 671 | P23743 | |
| ARQDCVKEIGLLKQL | 86 | Q9HC98 | |
| IGCKAKDIIRFLQQR | 1311 | Q5S007 | |
| ARCKLAELEGALQKA | 196 | A6NCN2 | |
| CEGLKQKNSVLARLG | 1086 | P59047 | |
| GLLAKKADLCQLIRD | 341 | Q9UKK3 | |
| ECNKLLAAKNINLRL | 341 | Q6ZMK1 | |
| RKKVCDIAAELARNL | 106 | O00410 | |
| RAHKQCALKLLRSGA | 186 | Q9BXW6 | |
| GDRSKQLALKVLCVA | 501 | Q86Y91 | |
| LGLKRELEALNKQCG | 5201 | Q9UPN3 | |
| LAREDKKLQCLGLQS | 256 | Q9BRP4 | |
| KALLAEIQNGCKRNL | 441 | O75864 | |
| RCQLNVLDNKKRTAL | 196 | A0JP26 | |
| RCQLNVLDNKKRTAL | 196 | Q6S8J3 | |
| RDCNKILDLVQKGLS | 1301 | Q9P2D7 | |
| QFQKLLVLRCLRGDK | 3621 | Q9P2D7 | |
| CKNDINILKCGSIRL | 241 | Q92896 | |
| TLLGNACQDCAKRKL | 321 | Q9NWS6 | |
| GLAKKCNLTERQVER | 101 | Q8IU89 | |
| KQNRKLCAGACVLLA | 556 | Q8TDN4 | |
| VLIALNEGKELCRQK | 266 | Q6ZMU1 | |
| RLKGEADLLCLDQKN | 416 | P10912 | |
| VQQCRASCKLLGREK | 476 | H7BZ55 | |
| LRNNLLQGRCRKKEA | 291 | A2CJ06 | |
| KCKRLIQLSVANNRL | 56 | Q8IW35 | |
| RACRAGKKQLALRSL | 271 | Q8WUX9 | |
| LKALCSILNQRAQGK | 726 | Q5SZL2 | |
| RAGNNRKVLRKCAAV | 1621 | Q9NSI6 | |
| LKELNQRIGKTECRN | 341 | Q5U623 | |
| HAQIKKGNRECERIL | 526 | Q9NTJ4 | |
| CLKNNELGKALRQIR | 2911 | Q5TBA9 | |
| TGLLNKCERIQGRKA | 671 | Q9UKV0 | |
| ELLQACGKLKRQLCA | 466 | Q92902 | |
| LLRECELQSQKLGKR | 131 | B5MCN3 | |
| GDKALQILRRIAKCN | 301 | O75751 | |
| LALKECIRALGQNKA | 521 | Q99661 | |
| RVDCKALRGKRLENI | 626 | O43933 | |
| KQNRKLCAGACVLLA | 401 | Q9BTV7 | |
| GQRCLNPKSKQARLI | 71 | O14625 | |
| CERVRDLLNPKNKGN | 151 | Q12756 | |
| LFKCIKLRTLNLGQN | 771 | Q7L1W4 | |
| LDQCLIGQTKENRRK | 2226 | Q12923 | |
| RCQLNVLDNKKRTAL | 196 | B2RU33 | |
| ALNQALKDLKALGCR | 186 | Q96RQ9 | |
| CEKGDKLRLFCLQLR | 361 | P41218 | |
| RCQLNVLDNKKRTAL | 196 | Q86YR6 | |
| RVNKEACLAGLRALQ | 141 | P53609 | |
| KKRLNRQLAALICGL | 2376 | O75691 | |
| AVNCREGKLVAKRRA | 746 | Q93008 | |
| NKACSLLGKLRLECA | 446 | Q6PI48 | |
| IALLKIRSKEGRCAQ | 276 | P00749 | |
| RDSCRKLSGLLRQKN | 51 | Q6UWJ1 | |
| CRRLRKNTGNQKALD | 181 | Q7Z3H4 | |
| LKLAELKQECLARGL | 11 | P82979 | |
| NLEKSCLAKLRVDGA | 431 | A6NFQ2 | |
| LDCILKRKAQQGVRI | 401 | Q13393 | |
| GDVTKRLLIQKNCLL | 96 | Q8NCA5 | |
| LDRRCQLNVLDNKKR | 156 | A0A0A6YYL3 | |
| LDRRCQLNVLDNKKR | 156 | P0CG39 | |
| KREAGLSRAQLLCQL | 241 | Q96JF0 | |
| GNRKAELRLCNKLVA | 1146 | Q8TE82 | |
| RCQLNVLDNKKRTAL | 196 | P0CG38 | |
| QQLESKRGRICAKRA | 466 | Q8TF30 | |
| RDQRGLCALKFLKLE | 436 | Q16512 | |
| GLKLLCRDKIRLNNA | 111 | Q9NP71 | |
| DCGKDLESVQRLLRK | 2391 | Q9NRC6 | |
| TCLLLLFAQKRGNVK | 81 | P78381 | |
| KERRSVLECRNKGVL | 1101 | Q8IY92 | |
| GLNELKLCFRVRLTK | 146 | P28288 | |
| CIIAKQRLAKGRIQA | 801 | Q2KHT3 | |
| KVNRARLKSLCALAA | 386 | Q7RTR0 | |
| RLLNIACAAKAKRRL | 371 | Q9Y4G8 | |
| SEARCKGLQALSLRK | 1411 | Q63HN8 | |
| RAKQNLERVCEKCGR | 851 | O95625 | |
| RRKLCLSQLQKGDKG | 311 | Q06732 | |
| ERCKKLGNNALLLNS | 416 | Q7Z3J2 | |
| CAGQAKVVRKLQGKR | 796 | Q96MK2 | |
| VRERNLNPKAACLKR | 606 | P15923 | |
| CKLDLKTIALRARNA | 176 | P20226 | |
| ALLDAAKKGCLARVQ | 806 | O95271 | |
| LLNVKCAAQTLEKRG | 631 | O75152 | |
| ADKIRVKIADLGNAC | 521 | P78362 | |
| LKNQIILKLSNGARC | 216 | Q9C0C9 | |
| ICLSIRDKRKQRQGE | 81 | Q9NW97 | |
| DRQGEVRLKCLKALQ | 341 | Q8WVM7 | |
| RVKGQGKKAIDCLRQ | 1026 | Q96AE7 | |
| QLIATLKNGRKICLD | 71 | P02776 | |
| CRHENLLLRKGCKNV | 106 | Q6ZMV8 | |
| GRLQKKLLQTRCKGR | 86 | Q6ZTR6 | |
| KLLLGQRCSLKVSGQ | 6 | Q8N7F7 | |
| TKAERLSKELLQCGR | 161 | Q5W5X9 | |
| LRQLNEQRKKGILCD | 351 | Q96DT7 | |
| GNLILSDCKRNLEVK | 1286 | Q9BXT5 | |
| QRKKQLLGCLIDSGA | 441 | O15050 | |
| RLFGKICNIRCLEKV | 206 | P51580 | |
| RCQLNILDNKKRTAL | 196 | Q6S5H5 | |
| RCQLNILDNKKRTAL | 196 | A6NI47 | |
| GLKCELQRKLAELQV | 1506 | Q68DK2 | |
| SVANRLLCEGQKGKL | 141 | Q9H6P5 | |
| GLKKQLRDLCGLNSE | 746 | P35125 | |
| REELKALSCLRCGKQ | 151 | Q8WUU4 | |
| RKALLACQGQLKKAA | 2656 | Q5THJ4 | |
| QRGDCALKDARAKLD | 376 | Q14CN4 |